On demand access to session content (videos and slides), including the ability to download posters and slides, available 6-12 hours after the live session Access to online meeting materials via am.asco.org including the ASCO Educational Book, Meeting Abstracts, Annual Meeting Program, and ASCO D...
text_snippet Videos & Slides 2023 ASCO Annual Meeting Phase II trial of neoadjuvant osimertinib for surgically resectableEGFR-mutated non-small cell lung cancer. First Author:Jacqueline V. Aredo, MD, MS text_snippet Abstract 2024 ASCO Gastrointestinal Cancers Symposium ...
刚刚落幕的2023年ASCO-GU大会在前列腺癌领域做了大量报道,其中在局限性前列腺癌(LPC)阶段也发布了多项更新。本文选取了在LPC阶段与新型内分泌治疗(NHT)治疗相关的四项主要研究,以主动监测(AS)、新辅助治疗、挽救性放疗(SRT)、生化复发(...
2023年ASCO年会数据:总参会人数44,400人,其中专业人士36,750人;参展商:6,000人;媒体及其他:1,650人;美国国内专业观众:22,750;国际与会者14,000人(中国有672人参会)。 美国临床肿瘤学会(ASCO)成立于1964年,是世界上最大、最具影响力的肿瘤专业学术组织,致力于癌症的预防、治疗及改善对患者的护理,ASCO是唯一...
[1] Pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor (TKI)-resistant, EGFR-mutant, metastatic nonsquamous NSCLC: Phase 3 KEYNOTE-789 study. https://meetings.asco.org/abstracts-presentations/218083/...
MID-MAY 2024: Oral Abstract and Poster Presenters' deadline to submit their presentation materials (slides, posters) on ASCO'sSpeaker Center Website 口头摘要和海报演讲者在ASCO演讲者中心网站上提交演讲材料(幻灯片,海报)截止日期 MAY 23, 2024, AT 5:00 PM (ET) ...
◆ 会议时间:2023年8月3日至5日 ◆ 会议地点:日本 横滨 ◆ 下次会议:2024年美国临床肿瘤学会突破峰会(ASCO Breakthrough) ◆ 会议简介: 2023年美国临床肿瘤学会突破峰会(ASCO Breakthrough)将于2023年8月3日至5日在日本横滨举行。ASCO Breakthrough是由美国临床肿瘤学会(ASCO)、日本临床肿瘤学会(JSCO)和日本肿瘤...
A webinar with accompanying slides will be available in theEventspage of the Investor Relations section of the Plus Therapeutics website beginning Friday, August 11, 2023 at 8:00 a.m. ET. The webcast will be available on the Company’s website for 90 d...
A webinar with accompanying slides will be available in theEventspage of the Investor Relations section of the Plus Therapeutics website beginning Friday, August 11, 2023 at 8:00 a.m. ET. The webcast will be available on the Company’s website for 90 da...
Clinical data and histopathology image data from pretreatment prostate biopsy slides were used to train the model to predict the benefit of long-term vs short-term ADT treatment on distant metastasis. Developed using patient data from six randomized, phase 3 NRG/RTOG trials of men receiving RT +...